Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Abuse-Deterrent Formulations of Prescription Opioids.
Dart RC, Severtson SG, Green JL. Dart RC, et al. Among authors: severtson sg. JAMA Psychiatry. 2015 Aug;72(8):849. doi: 10.1001/jamapsychiatry.2015.0723. JAMA Psychiatry. 2015. PMID: 26153845 No abstract available.
Unit-Dose Packaging and Unintentional Buprenorphine-Naloxone Exposures.
Wang GS, Severtson SG, Bau GE, Dart RC, Green JL. Wang GS, et al. Among authors: severtson sg. Pediatrics. 2018 Jun;141(6):e20174232. doi: 10.1542/peds.2017-4232. Epub 2018 May 3. Pediatrics. 2018. PMID: 29724879 Free article. Clinical Trial.
Abuse and diversion of buprenorphine sublingual tablets and film.
Lavonas EJ, Severtson SG, Martinez EM, Bucher-Bartelson B, Le Lait MC, Green JL, Murrelle LE, Cicero TJ, Kurtz SP, Rosenblum A, Surratt HL, Dart RC. Lavonas EJ, et al. J Subst Abuse Treat. 2014 Jul;47(1):27-34. doi: 10.1016/j.jsat.2014.02.003. Epub 2014 Mar 3. J Subst Abuse Treat. 2014. PMID: 24680219
Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison Centers.
Butler SF, Black RA, Severtson SG, Dart RC, Green JL. Butler SF, et al. Among authors: severtson sg. J Subst Abuse Treat. 2018 Jan;84:42-49. doi: 10.1016/j.jsat.2017.10.010. Epub 2017 Oct 27. J Subst Abuse Treat. 2018. PMID: 29195592
Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010.
Severtson SG, Bartelson BB, Davis JM, Muñoz A, Schneider MF, Chilcoat H, Coplan PM, Surratt H, Dart RC. Severtson SG, et al. J Pain. 2013 Oct;14(10):1122-30. doi: 10.1016/j.jpain.2013.04.011. Epub 2013 Jun 29. J Pain. 2013. PMID: 23816949
Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
Severtson SG, Ellis MS, Kurtz SP, Rosenblum A, Cicero TJ, Parrino MW, Gilbert MK, Buttram ME, Dasgupta N, BucherBartelson B, Green JL, Dart RC. Severtson SG, et al. Drug Alcohol Depend. 2016 Nov 1;168:219-229. doi: 10.1016/j.drugalcdep.2016.09.018. Epub 2016 Oct 3. Drug Alcohol Depend. 2016. PMID: 27716575 Free article.
Comparative Rates of Mortality and Serious Adverse Effects Among Commonly Prescribed Opioid Analgesics.
Murphy DL, Lebin JA, Severtson SG, Olsen HA, Dasgupta N, Dart RC. Murphy DL, et al. Among authors: severtson sg. Drug Saf. 2018 Aug;41(8):787-795. doi: 10.1007/s40264-018-0660-4. Drug Saf. 2018. PMID: 29582394 Clinical Trial.
Trends in abuse and misuse of prescription opioids among older adults.
West NA, Severtson SG, Green JL, Dart RC. West NA, et al. Drug Alcohol Depend. 2015 Apr 1;149:117-21. doi: 10.1016/j.drugalcdep.2015.01.027. Epub 2015 Jan 31. Drug Alcohol Depend. 2015. PMID: 25678441
Using poison center exposure calls to predict prescription opioid abuse and misuse-related emergency department visits.
Davis JM, Severtson SG, Bucher-Bartelson B, Dart RC. Davis JM, et al. Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):18-25. doi: 10.1002/pds.3533. Epub 2013 Oct 16. Pharmacoepidemiol Drug Saf. 2014. PMID: 24130046
Assessment of prescription opioid intentional exposures across the rural-urban continuum in the United States using both population and drug availability rates.
Le Lait MC, Martinez EM, Severtson SG, Lavery SA, Bucher-Bartelson B, Dart RC. Le Lait MC, et al. Pharmacoepidemiol Drug Saf. 2014 Dec;23(12):1334-7. doi: 10.1002/pds.3653. Epub 2014 Jun 4. Pharmacoepidemiol Drug Saf. 2014. PMID: 24899151
29 results
Jump to page
Feedback